🧫

Longitudinal plasma biomarker study measuring Aβ42:Aβ40 ratio, p-tau181, NfL, and GFAP at midlife and late life in 1525 ARIC participants found that decreasing Aβ42:Aβ40 and increasing p-tau181, NfL, and GFAP over time were associated with incident all-cause dementia, with the strongest late-life as

active
experiment Created: 2026-04-27T23:24:34 By: etl-v1-backfill Quality: 50% ✓ SciDEX ID: exp-6fc9683e936c
🧫 Experiment Protocol ClinicalAlzheimer's diseaseAPOEhumanextracted
Plasma biomarkers measured using Quanterix Simoa platform; incident dementia ascertained from neuropsychological assessments, participant contact, and medical record surveillance from 2012-2019.
PRIMARY OUTCOME
Longitudinal plasma biomarker study measuring Aβ42:Aβ40 ratio, p-tau181, NfL, and GFAP at midlife and late life in 1525 ARIC participants found that decreasing Aβ42:Aβ40 and increasing p-tau181, NfL, and GFAP over time were associated with incident all-cause dementia, with the strongest late-life association for NfL (HR 1.92).
Source: pmid_39068543
🧫 Experiment Extras
PATHWAY
lipid metabolism/apolipoprotein function
MARKET PRICE
$0.50
STATUS
extracted
Related Target
APOEcomposite 0.621
Metadataorigin_type: v1_polymorphic_backfill
origin_typev1_polymorphic_backfill
source_tableexperiments
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.